Stay updated on DARA/ATRA Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.

Latest updates to the DARA/ATRA Combo in Myeloma: Clinical Trial page
- Check6 days agoChange DetectedFooter now shows Revision: v3.4.2. The previous government funding/operating-status notice (Revision: v3.4.1) has been removed.SummaryDifference0.4%

- Check13 days agoChange DetectedAdded a site-wide funding/status notice about a government lapse and NIH Clinical Center operations. Updated related topics (Multiple myeloma; MedlinePlus Genetics) and revised the page version from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check20 days agoChange DetectedShow glossary is now displayed, and there are small editorial updates including capitalization changes and the addition of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The page also removes 'Multiple myeloma' from related topics and updates the revision from v3.3.4 to v3.4.0.SummaryDifference0.4%

- Check27 days agoChange DetectedRelated topics were added to the page: Multiple myeloma and MedlinePlus Genetics, which are minor contextual additions to the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This is a small, non-functional update to the page.SummaryDifference0.1%

- Check55 days agoChange DetectedDifference0.4%

Stay in the know with updates to DARA/ATRA Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.